|
Market Closed -
Börse Stuttgart
05:55:42 19/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 11.48 EUR | -1.54% |
|
-11.15% | +125.10% |
| 15/09 | French and Benelux stocks-Factors to watch on September 15 | RE |
| 15/09 | France's Genfit Plans Phase 2a Trial of Liver Failure Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 46.28B | |||||
| 43.85B | |||||
| 40.93B | - | - | - | - | - |
| 39.89B | |||||
| 29.5B |
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
- Charts GENFIT
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
